Your browser doesn't support javascript.
loading
Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation.
Zhai, Tianyu; Zhang, Xiaoyu; Hei, Zhenyu; Jin, Longyang; Han, Chao; Ko, Audrey Tsznam; Yu, Xiaofeng; Wang, Jiandong.
Affiliation
  • Zhai T; Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang X; Shanghai Research Center of Biliary Tract Disease, Shanghai, China.
  • Hei Z; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
  • Jin L; Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Han C; Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ko AT; Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Yu X; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang J; Faculty of Medicine, Imperial College London, London, United Kingdom.
Front Pharmacol ; 12: 792330, 2021.
Article in En | MEDLINE | ID: mdl-34744756
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2021.628621.].
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: China